IVACAFTOR and DEATH

Overview

DEATH is the #7 most commonly reported adverse reaction for IVACAFTOR, manufactured by Vertex Pharmaceuticals Incorporated. There are 224 FDA adverse event reports linking IVACAFTOR to DEATH. This represents approximately 2.4% of all 9,200 adverse event reports for this drug.

Patients taking IVACAFTOR who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DEATH is a less commonly reported adverse event for IVACAFTOR, but still significant enough to appear in the safety profile.

Other Side Effects of IVACAFTOR

In addition to death, the following adverse reactions have been reported for IVACAFTOR:

• HOSPITALISATION — 1,286 reports
• INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS — 601 reports
• PNEUMONIA — 262 reports
• INFECTION — 249 reports
• MALAISE — 247 reports
• LOWER RESPIRATORY TRACT INFECTION — 242 reports
• COUGH — 219 reports
• CYSTIC FIBROSIS — 211 reports
• HEADACHE — 194 reports
• NASOPHARYNGITIS — 168 reports

Other Drugs Associated with DEATH

The following drugs have also been linked to death in FDA adverse event reports:

Does IVACAFTOR cause DEATH?

DEATH has been reported as an adverse event in 224 FDA reports for IVACAFTOR. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DEATH with IVACAFTOR?

DEATH accounts for approximately 2.4% of all adverse event reports for IVACAFTOR, making it a notable side effect.

What should I do if I experience DEATH while taking IVACAFTOR?

If you experience death while taking IVACAFTOR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages